{"id":204744,"name":"GENALYTE","slug":"genalyte","state":"CA","country":"United States of America","description":"Develops and markets high-quality, mobile diagnostic tests","totalSpending":106000,"filings":7,"yearlySpending":[{"year":2020,"income":106000},{"year":2021,"income":0}],"issues":[{"code":"DEF","display":"Defense"},{"code":"VET","display":"Veterans"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"HCR","display":"Health Issues"}],"firms":["MEHLMAN CONSULTING, INC."],"lobbyists":["DAVID THOMAS","DEAN ROSEN","ELISE FINLEY PICKERING","DAVID CASTAGNETTI","BRUCE MEHLMAN","SAGE EASTMAN","LAUREN ARONSON","MICHAEL ROBINSON","CONSTANTINE HINGSON","STEVE HARO","HELEN TOLAR","NICHOLE DISTEFANO","MCKENZIE BRICE","PAUL THORNELL"],"govEntities":["Food & Drug Administration (FDA)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","Natl Institutes of Health (NIH)","Office of the Vice President of the United States","SENATE","White House Office"],"sampleDescriptions":["Expanded access to mobile, rapid diagnostic testing for COVID-19, including appropriate funding and regulatory authorities necessary for scale and deployment.","Expanded access to mobile, rapid diagnostic testing for COVID-19, including appropriate funding and regulatory authorities necessary for scale and deployment.","Expanded access to mobile, rapid diagnostic testing for COVID-19, including appropriate funding and regulatory authorities necessary for scale and deployment.","Expanded access to mobile, rapid diagnostic testing for COVID-19, including appropriate funding and regulatory authorities necessary for scale and deployment.","H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act- Implementation\nH.R. 6201, Families First Coronavirus Response Act- Implementation\nH.R. 748, Coronavirus Aid, Relief, a"]}